JEANNE HABASH: Open Payments
NPI 1376593947 · GREAT BEND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 13 payments from 7 companies in 2025. Trend: 2023 $67 · 2024 $231 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Abbott Laboratories | 2 | $46 |
| Novo Nordisk Inc | 2 | $39 |
| ABBVIE INC. | 1 | $23 |
| Seqirus USA Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: REXULTI, FARXIGA, FREESTYLE LIBRE 3, Ozempic, QULIPTA, Fluad, SHINGRIX, Rybelsus.
Industry payments across KS — which companies pay providers there.
